IP Verse
Top Law Firms
Unified Patent Court
Trending Technologies
Blogs
Contact Us
Toggle menu
Tcr2 Therapeutics Inc. opposition analysis
COMPANY ANALYSIS
Latest patents of Tcr2 Therapeutics Inc. opposed by its competitors
Patent:
EP3298033
Grant Date:
Jul 12, 2023
Title:
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins
Oppositions:
1
Latest patents of Tcr2 Therapeutics Inc. opposed by its competitors
Patent Number
Grant Date
Title
Total Oppositions
EP3298033
Jul 12, 2023
Compositions And Methods For Tcr Reprogramming Using Fusion Proteins
1
Competitors of Tcr2 Therapeutics Inc.
JONES DAY
Want to track Tcr2 Therapeutics Inc.?
Feel free to send us a message here and we will get back to you
Name
Email
Message
Let's get in touch